- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

Patient in ACTC Stem Cell Clinical Trial With Dry AMD Goes from Legally Blind (20/400) to Near Normal Vision (20/40)

Posted By Irv Arons On May 20, 2013 @ 5:30 am In Clinical Trials,Industry News,Macular Degeneration,New Technologies,Research,Retina,Stem Cell Therapies | Comments Disabled

As you may know, Advanced Cell Technology is currently running three stem cell clinical trials [1]; two for treating Stargardt’s Disease, one in the U.S. and one in the UK; and one clinical trial in the U.S. for treating the dry form of AMD.

Due to a unique set of circumstances, it was disclosed that one of the dry AMD patients has gone from 20/400 (legally blind) to 20/40 (near normal vision). This is an amazing development.

Here is the story behind the story of how this disclosure occurred.

To read the story, please follow this link. [2]

Here is a link to the company’s press release [3] concerning the development.

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/007096-patient-in-actc-stem-cell-clinical-trial-for-dry-amd-goes-from-legally-blind-20400-to-near-normal-vision-2040/

URLs in this post:

[1] three stem cell clinical trials: http://eyedocnews.com/006717-act-secures-approval-to-proceed-with-increased-rpe-dosage-for-patients-in-clinical-trial-for-dry-amd/

[2] link.: http://tinyurl.com/StemCellUpdate25

[3] press release: http://advancedcell.com/news-and-media/press-releases/act-confirms-clinical-trial-participant-showed-improvement-in-vision-from-20-400-to-20-40-following-treatment/index.asp

Copyright © 2008 Eye Doc Talk. All rights reserved.